GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTF) » Definitions » Pre-Tax Income

Relief Therapeutics Holding (Relief Therapeutics Holding) Pre-Tax Income : $-99.37 Mil (TTM As of Jun. 2023)


View and export this data going back to 1990. Start your Free Trial

What is Relief Therapeutics Holding Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Relief Therapeutics Holding's pretax income for the six months ended in Jun. 2023 was $-71.24 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was $-99.37 Mil. Relief Therapeutics Holding's pretax margin was -2,122.04%.

During the past 13 years, Relief Therapeutics Holding's highest Pretax Margin was -60.45%. The lowest was -1541.27%. And the median was -483.42%.


Relief Therapeutics Holding Pre-Tax Income Historical Data

The historical data trend for Relief Therapeutics Holding's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Pre-Tax Income Chart

Relief Therapeutics Holding Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.42 -12.38 -7.05 -38.57 -58.30

Relief Therapeutics Holding Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.16 -22.65 -28.97 -28.13 -71.24

Competitive Comparison of Relief Therapeutics Holding's Pre-Tax Income

For the Biotechnology subindustry, Relief Therapeutics Holding's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Relief Therapeutics Holding's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Pre-Tax Income falls into.



Relief Therapeutics Holding Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Relief Therapeutics Holding's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-39.483+0+-0.167+0.019+-18.673
=-58.30

Relief Therapeutics Holding's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-12.834+0+-0.204+0+-58.199
=-71.24

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-99.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Relief Therapeutics Holding  (OTCPK:RLFTF) Pre-Tax Income Explanation

Relief Therapeutics Holding's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-71.237/3.357
=-2,122.04%

During the past 13 years, Relief Therapeutics Holding's highest Pretax Margin was -60.45%. The lowest was -1541.27%. And the median was -483.42%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Relief Therapeutics Holding Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Relief Therapeutics Holding (Relief Therapeutics Holding) Business Description

Traded in Other Exchanges
Address
Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.

Relief Therapeutics Holding (Relief Therapeutics Holding) Headlines

From GuruFocus